AP2008004602A0 - Melanocortin type 4 receptor agonist piperidinoylpyrrolidines - Google Patents
Melanocortin type 4 receptor agonist piperidinoylpyrrolidinesInfo
- Publication number
- AP2008004602A0 AP2008004602A0 AP2008004602A AP2008004602A AP2008004602A0 AP 2008004602 A0 AP2008004602 A0 AP 2008004602A0 AP 2008004602 A AP2008004602 A AP 2008004602A AP 2008004602 A AP2008004602 A AP 2008004602A AP 2008004602 A0 AP2008004602 A0 AP 2008004602A0
- Authority
- AP
- ARIPO
- Prior art keywords
- piperidinoylpyrrolidines
- receptor agonist
- melanocortin type
- melanocortin
- type
- Prior art date
Links
- 108010008364 Melanocortins Proteins 0.000 title 1
- 239000002865 melanocortin Substances 0.000 title 1
- IOONOXRAIWLNPF-UHFFFAOYSA-N piperidin-1-yl(pyrrolidin-1-yl)methanone Chemical class C1CCCCN1C(=O)N1CCCC1 IOONOXRAIWLNPF-UHFFFAOYSA-N 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77629506P | 2006-02-23 | 2006-02-23 | |
| US88784007P | 2007-02-02 | 2007-02-02 | |
| PCT/IB2007/000456 WO2007096763A2 (en) | 2006-02-23 | 2007-02-19 | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2008004602A0 true AP2008004602A0 (en) | 2008-10-31 |
Family
ID=38169450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2008004602A AP2008004602A0 (en) | 2006-02-23 | 2007-02-19 | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8138188B2 (pt) |
| EP (1) | EP1989196B1 (pt) |
| KR (1) | KR101036981B1 (pt) |
| AP (1) | AP2008004602A0 (pt) |
| AU (1) | AU2007219236B2 (pt) |
| BR (1) | BRPI0708264A2 (pt) |
| CA (1) | CA2642922C (pt) |
| CR (1) | CR10219A (pt) |
| DK (1) | DK1989196T3 (pt) |
| EA (1) | EA200801738A1 (pt) |
| EC (1) | ECSP088688A (pt) |
| ES (1) | ES2402581T3 (pt) |
| IL (1) | IL193279A (pt) |
| MA (1) | MA30228B1 (pt) |
| ME (1) | MEP6808A (pt) |
| MX (1) | MX2008010899A (pt) |
| NO (1) | NO20083480L (pt) |
| RS (1) | RS20080371A (pt) |
| SG (1) | SG185849A1 (pt) |
| TN (1) | TNSN08337A1 (pt) |
| WO (1) | WO2007096763A2 (pt) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2019100A1 (en) * | 2007-07-19 | 2009-01-28 | Santhera Pharmaceuticals (Schweiz) AG | Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US8902867B2 (en) | 2007-11-16 | 2014-12-02 | Qualcomm Incorporated | Favoring access points in wireless communications |
| US8848656B2 (en) | 2007-11-16 | 2014-09-30 | Qualcomm Incorporated | Utilizing broadcast signals to convey restricted association information |
| US9603062B2 (en) | 2007-11-16 | 2017-03-21 | Qualcomm Incorporated | Classifying access points using pilot identifiers |
| US8737295B2 (en) | 2007-11-16 | 2014-05-27 | Qualcomm Incorporated | Sector identification using sector parameters signatures |
| EP2103614A1 (en) * | 2008-03-18 | 2009-09-23 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| US8588773B2 (en) | 2008-08-04 | 2013-11-19 | Qualcomm Incorporated | System and method for cell search and selection in a wireless communication system |
| UA99555C2 (en) | 2008-11-12 | 2012-08-27 | Элджи Лайф Саенсез Лтд. | Melanocortin receptor agonists |
| CN106512010A (zh) * | 2009-11-18 | 2017-03-22 | 赫尔辛医疗股份公司 | 用于治疗中枢介导的恶心及呕吐的组合物及方法 |
| EP2722045B1 (en) | 2009-11-18 | 2016-07-06 | Helsinn Healthcare SA | Compositions for treating centrally mediated nausea and vomiting |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| PT3333165T (pt) | 2015-08-04 | 2019-10-29 | Astellas Pharma Inc | Derivado de piperazina |
| EP3870292A4 (en) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA |
| PE20231215A1 (es) | 2020-06-09 | 2023-08-17 | Pfizer | Compuestos espiro como antagonistas del receptor de melanocortina 4 y usos de los mismos |
| CA3241470A1 (en) | 2021-12-06 | 2023-06-15 | Pfizer Inc. | Melanocortin 4 receptor antagonists and uses thereof |
| WO2025228892A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228899A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Further heterocyclic compounds as sting antagonists and the use thereof as medicament |
| WO2025228889A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament |
| US20250333414A1 (en) | 2024-04-30 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228902A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Heterocyclic acids as sting antagonists and the use thereof as medicament |
| WO2025228900A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Arylamide substituted indazoles and the use thereof as medicament |
| US12605394B2 (en) | 2024-07-25 | 2026-04-21 | Visionary Assets, Llc | Compositions containing cannabinoid nanoparticles |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH507249A (de) | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| GB8531071D0 (en) | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| CA2098167C (en) | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
| TW381025B (en) | 1993-08-05 | 2000-02-01 | Hoffmann La Roche | Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor |
| US5596106A (en) | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| DE4435477A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| US5521186A (en) | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
| ES2155535T3 (es) | 1994-10-27 | 2001-05-16 | Janssen Pharmaceutica Nv | Inhibidores de sintesis de apoliproteina b. |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| IL141769A0 (en) | 1998-09-11 | 2002-03-10 | Aventis Pharma Sa | Azetidine derivatives, preparation and medicines containing them |
| FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
| AU2002230843B8 (en) | 2000-12-14 | 2007-05-17 | Amylin Pharmaceuticals, Llc | Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| GEP20053710B (en) | 2001-02-28 | 2005-12-26 | Merck & Co Inc | Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists |
| EP1372653B1 (en) | 2001-02-28 | 2006-10-04 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| ATE284872T1 (de) | 2001-03-22 | 2005-01-15 | Solvay Pharm Bv | 4,5-dihydro-1h-pyrazolderivate mit cb1- antagonistischer wirkung |
| AU2002353784B2 (en) | 2001-09-24 | 2008-04-10 | Oregon Health And Science University | Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| EP1482794A1 (en) | 2002-03-06 | 2004-12-08 | Merck & Co., Inc. | Method of treatment or prevention of obesity |
| MXPA05000962A (es) | 2002-07-29 | 2005-05-16 | Hoffmann La Roche | Nuevos benzodioxoles. |
| US7091216B2 (en) | 2002-08-02 | 2006-08-15 | Merck & Co., Inc. | Substituted furo[2,3-b]pyridine derivatives |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| MY134457A (en) | 2002-11-22 | 2007-12-31 | Merck & Co Inc | Substituted amides |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7151097B2 (en) | 2003-11-07 | 2006-12-19 | Pfizer Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| GB0402492D0 (en) | 2004-02-04 | 2004-03-10 | Pfizer Ltd | Pharmaceutically active compounds |
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| WO2007015162A1 (en) * | 2005-08-04 | 2007-02-08 | Pfizer Limited | Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| CA2731897C (en) | 2008-08-06 | 2013-07-02 | Pfizer Limited | Diazepine and diazocane compounds as mc4 agonists |
-
2007
- 2007-02-19 AP AP2008004602A patent/AP2008004602A0/xx unknown
- 2007-02-19 MX MX2008010899A patent/MX2008010899A/es active IP Right Grant
- 2007-02-19 ES ES07705650T patent/ES2402581T3/es active Active
- 2007-02-19 KR KR1020087023101A patent/KR101036981B1/ko not_active Expired - Fee Related
- 2007-02-19 SG SG2011037132A patent/SG185849A1/en unknown
- 2007-02-19 WO PCT/IB2007/000456 patent/WO2007096763A2/en not_active Ceased
- 2007-02-19 DK DK07705650.5T patent/DK1989196T3/da active
- 2007-02-19 US US12/280,444 patent/US8138188B2/en not_active Expired - Fee Related
- 2007-02-19 RS RSP-2008/0371A patent/RS20080371A/sr unknown
- 2007-02-19 EA EA200801738A patent/EA200801738A1/ru unknown
- 2007-02-19 AU AU2007219236A patent/AU2007219236B2/en not_active Ceased
- 2007-02-19 BR BRPI0708264-9A patent/BRPI0708264A2/pt not_active Application Discontinuation
- 2007-02-19 EP EP07705650A patent/EP1989196B1/en active Active
- 2007-02-19 ME MEP-68/08A patent/MEP6808A/xx unknown
- 2007-02-19 CA CA2642922A patent/CA2642922C/en not_active Expired - Fee Related
-
2008
- 2008-08-06 IL IL193279A patent/IL193279A/en not_active IP Right Cessation
- 2008-08-11 NO NO20083480A patent/NO20083480L/no not_active Application Discontinuation
- 2008-08-19 CR CR10219A patent/CR10219A/es unknown
- 2008-08-21 EC EC2008008688A patent/ECSP088688A/es unknown
- 2008-08-22 TN TNP2008000337A patent/TNSN08337A1/fr unknown
- 2008-08-22 MA MA31190A patent/MA30228B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1989196T3 (da) | 2013-04-15 |
| ES2402581T3 (es) | 2013-05-06 |
| ECSP088688A (es) | 2008-10-31 |
| HK1126489A1 (en) | 2009-09-04 |
| MEP6808A (xx) | 2010-02-10 |
| US20090036459A1 (en) | 2009-02-05 |
| EP1989196A2 (en) | 2008-11-12 |
| EA200801738A1 (ru) | 2008-12-30 |
| WO2007096763A3 (en) | 2007-10-18 |
| KR101036981B1 (ko) | 2011-05-25 |
| AU2007219236B2 (en) | 2012-06-21 |
| NO20083480L (no) | 2008-09-10 |
| TNSN08337A1 (fr) | 2009-12-29 |
| US8138188B2 (en) | 2012-03-20 |
| IL193279A (en) | 2012-12-31 |
| BRPI0708264A2 (pt) | 2011-05-24 |
| IL193279A0 (en) | 2009-02-11 |
| CR10219A (es) | 2008-09-23 |
| AU2007219236A1 (en) | 2007-08-30 |
| RS20080371A (sr) | 2009-07-15 |
| EP1989196B1 (en) | 2013-02-13 |
| WO2007096763A2 (en) | 2007-08-30 |
| CA2642922A1 (en) | 2007-08-30 |
| CA2642922C (en) | 2011-08-02 |
| SG185849A1 (en) | 2012-12-28 |
| KR20080095918A (ko) | 2008-10-29 |
| MX2008010899A (es) | 2008-11-27 |
| MA30228B1 (fr) | 2009-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL193279A0 (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| EP2041120A4 (en) | MELANOCORTIN RECEPTOR AGONISTS | |
| IL201732A0 (en) | Melanocortin receptor ligands | |
| IL200845A0 (en) | Oligomer-opoid agonist conjugates | |
| PL2018165T3 (pl) | Związki dimerowe agonistyczne wobec receptorów FGF | |
| EP2017281A4 (en) | AGONISTS AT TOLL-LIKE RECEPTOR 9 | |
| ZA200902449B (en) | Selective TR-Beta 1 agonist | |
| GB201000798D0 (en) | Poly-TLR antagonists | |
| ZA200806992B (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| IL198618A (en) | Affluent acting on adenosine receptors | |
| GB0516946D0 (en) | Receptor | |
| HK1127607A (en) | Melanocortin receptor agonists | |
| GB0604684D0 (en) | Receptor | |
| GB0608516D0 (en) | Receptor | |
| GB0623853D0 (en) | Receptor | |
| GB0623399D0 (en) | Receptor | |
| GB0510253D0 (en) | Receptor | |
| GB0522077D0 (en) | Receptor | |
| GB0522394D0 (en) | Receptor | |
| GB0522484D0 (en) | Receptor | |
| TWM299239U (en) | Improved screw structure | |
| GB0615465D0 (en) | Type 9 saddle | |
| GB0604926D0 (en) | MoveClick 15 | |
| GB0604578D0 (en) | Corcost 6 | |
| GB0601236D0 (en) | MoveClick 7 |